Table 1 The relationships between NKX6.3, p53, EP300 and AICDA protein expression and clinical pathological parameters in gastric cancer.

Total

33

118

<0.0001

65

86

0.1036

60

91

0.0146

54

97

0.0006

Tumor volume

0.9364

0.3856

0.5741

0.6175

    <6.5

18

63

38

43

30

51

27

54

   ≥6.5

15

55

27

43

30

40

27

43

Gender

0.4212

0.599

0.392

0.3827

   Male

25

73

40

58

41

57

38

60

   Female

8

45

25

28

19

34

16

37

Age

0.9364

0.3856

0.5741

0.6175

   ≤60

20

69

34

55

37

52

31

58

   >60

13

49

31

31

23

39

23

39

Site

0.4212

0.599

0.392

0.6237

   Upper

5

10

5

10

8

7

4

11

   Lower

28

108

60

76

52

84

50

86

L/N metastasis

0.8262

0.8059

0.7136

0.6033

   LN (+)

32

116

63

85

59

89

52

96

   LN (−)

1

2

2

1

1

2

2

1

Tumor stage

0.0026

0.2302

0.0553

0.039

   T1

0

0

0

0

0

0

0

0

   T2

18

28

18

28

24

22

10

36

   T3

15

87

47

55

36

66

42

60

   T4

0

3

0

3

0

3

2

1

N stage

<0.0001

0.148

0.0889

0.4184

   N0

3

0

3

0

3

0

0

3

   N1

10

9

10

9

10

9

5

14

   N2

9

25

15

19

13

21

12

22

   N3

11

84

37

58

34

61

37

58

TNM stage

<0.0001

0.1373

0.029

0.0539

   I

1

0

1

0

1

0

0

1

   II

17

9

15

11

16

10

5

21

   III

15

107

49

73

43

79

47

75

   IV

0

2

0

2

0

2

2

0

Lauren’s

0.3217

0.5166

0.324

0.3694

   intestinal

11

53

30

34

22

42

26

38

   diffuse

22

65

35

52

38

49

28

59

p53

0.6066

   +

16

49

   −

17

69

EP300

<0.0001

0.8214

   +

25

35

27

33

   −

8

85

38

53

AICDA

<0.0001

0.4394

0.0056

   +

0

54

26

28

13

41

   −

33

64

39

58

47

50